Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International Inc. reports developments across its cigarette business and expanding smoke-free portfolio, including IQOS heated tobacco products, ZYN nicotine pouches and e-vapor offerings. Company news commonly covers quarterly results, shipment and revenue trends, product authorizations, brand collaborations, and updates tied to adult-smoker alternatives.
Recurring announcements also address U.S. and international regulatory matters, including FDA modified-risk tobacco product authorizations for IQOS, as well as annual shareholder meetings, board elections, executive compensation votes, auditor ratification, shareholder proposals, and corporate responsibility initiatives.
Philip Morris International U.S. (NYSE:PM) will invest approximately $50 million to open a new Business Solutions Center in Tampa, Florida, creating about 180 direct and indirect high-skilled jobs. The center consolidates business solutions, distribution and customer service and includes a 10-year lease commitment at Highwoods Bay Center.
Since 2022, PMI U.S. has invested more than $1 billion in U.S. manufacturing and operations, including a $600 million ZYN facility in Aurora, CO, a $232 million expansion in Owensboro, KY, and philanthropic contributions of about $35 million.
Hidden Wounds (Sumter, SC) received a $50,000 donation from Philip Morris International U.S. (PM) to expand rapid mental‑health stabilization, suicide prevention, peer support, and essential services for at‑risk veterans.
Hidden Wounds reported 2025 service metrics (8,000+ fed, 87 nursing‑home patients, 15 housed) and began Village Alpha housing construction in February 2026.
Philip Morris International (NYSE: PM) declared a regular quarterly dividend of $1.47 per share, payable April 13, 2026 to shareholders of record March 19, 2026 (ex-dividend date March 19, 2026).
PMI reports its smoke-free products were used by over 43 million legal-age consumers as of December 31, 2025, represent 41.5% of full year 2025 net revenues, are sold in over 105 markets, and the company has invested $16 billion since 2008 in smoke-free R&D and commercialization. The company also notes FDA marketing and Modified Risk Tobacco Product authorizations for certain products.
Philip Morris International (NYSE:PM) announced a $150,000 grant to the California Asian Pacific Chamber of Commerce on March 4, 2026 to support the Main Street Small Business Impact Program and Small Business Utilization Center.
This brings PMI U.S.'s total support to $350,000 over two years and includes a PMI U.S. director joining the Chamber's board to expand assistance for AAPI and disadvantaged entrepreneurs across California.
Philip Morris (NYSE: PM) presented at the 2026 CAGNY Conference and reaffirmed its 2026 full-year reported diluted EPS forecast of $7.87 to $8.02 on February 18, 2026.
Excluding a total 2026 adjustment of $0.51, adjusted diluted EPS is forecast at $8.38–$8.53, representing 11.1%–13.1% growth versus $7.54 in 2025; excluding a favorable currency impact of $0.27, growth is 7.5%–9.5%. The company said underlying assumptions remain unchanged and the webcast replay will be available for six months.
Philip Morris International (NYSE: PM) will present at the CAGNY Conference on February 18, 2026 at 10:00 a.m. ET via a live audio webcast featuring Group CEO Jacek Olczak and CFO Emmanuel Babeau.
The webcast, slides and six-month replay will be available via the company’s IR site and mobile app. The release highlights PMI’s smoke-free portfolio, 2025 metrics and past R&D investment.
Philip Morris International (NYSE: PM) reported full-year 2025 results with reported diluted EPS $7.26 and adjusted diluted EPS $7.54 (adjusted EPS +14.8% vs. 2024; +14.2% currency‑neutral). Net revenues exceeded $40.6 billion, with the smoke‑free business contributing ~$17 billion and representing 41.5% of net revenues.
The company delivered SFP shipment volume +12.8% and gross profit for SFP +20.3%, declared a quarterly dividend of $1.47, and provided 2026–2028 organic growth targets for revenues, operating income, and adjusted EPS.
Philip Morris International (NYSE: PM) will host a live audio webcast on Friday, February 6, 2026 at 9:00 a.m. ET to discuss its 2025 fourth-quarter and full-year results, which will be released at about 7:00 a.m. ET the same day.
The webcast is listen-only, will feature CEO Jacek Olczak and CFO Emmanuel Babeau, includes a Q&A session, and will be recorded and available for one year.
Philip Morris International (NYSE: PM) asked the FDA advisory committee to recommend authorizing ZYN nicotine pouches as a Modified Risk Tobacco Product (MRTP), arguing switching completely from cigarettes to ZYN reduces risk of six smoking-related diseases.
The company noted ZYN received PMTA marketing authorization in January 2025, presented evidence of substantially lower harmful chemical levels versus cigarettes, and cited consumer data: a majority who tried ZYN stopped cigarettes in the past 30 days or reduced use (80.7% reduced consumption; 57.2% cut cigarettes/day by >50%). PMI highlighted its smoke-free portfolio: 41% of first‑nine months 2025 net revenues and > 41 million legal‑age users as of June 30, 2025.
Philip Morris International (NYSE: PM) released a white paper, “Human Cognition: The Next Frontier?”, calling for global dialogue on protecting and enhancing human cognitive skills as AI automates cognitive work.
The company reiterated its strategic shift to a smoke-free future: smoke-free products are available in 100+ markets, used by an estimated 41 million legal-age consumers as of June 30, 2025, and accounted for 41% of first-nine months 2025 net revenues. PMI said it has invested $14 billion since 2008 in smoke-free product development and aims to be predominantly smoke-free by 2030. The release also notes recent FDA marketing and modified-risk authorizations for certain products and highlights cognitive risks from AI such as atrophy, attention erosion, verification challenges, and a growing cognitive divide.